Healthcare & Life Science

KO client Nanospectra Biosciences, a medical device company that is pioneering a novel use of nanomedicine to destroy tumors without damaging adjacent healthy tissue, recently closed a $3 million Series B-1 financing with total approved capital of up to $6 million. The financing will be used for additional development and…

Koenig, Oelsner, Taylor, Schoenfeld & Gaddis PC (KO Law Firm) has announced the expansion of its commercial practice with the addition of attorney Christine Hofmeister. Christine counsels health care, life science, technology and professional services clients on a variety of commercial and transactional matters. Christine specializes in drafting and negotiating a wide…

Koenig, Oelsner, Taylor, Schoenfeld & Gaddis PC (KO Law Firm) has announced the expansion of its commercial and data privacy and security practices with the addition of attorney and data privacy expert Erin Locker. Erin joins KO Law Firm following several years at two international law firms. Erin’s practice focuses…

Businesses are facing significant challenges and uncertainty in light of the COVID-19 pandemic. Several new laws provide relief for businesses and employees, but businesses must still consider pre-existing legal and contractual factors during the current circumstances. The following guide gives businesses a solid foundation for navigating some of the most common…

In a tight labor market, it’s often the benefits and perks that help employers compete for talent. One key benefit an employer must consider is vacation. Should vacation be offered, and if so, how much and how should it be structured? What’s the real value of vacation to employees and…

Most life sciences companies negotiate numerous commercial contracts each year and must rely on big industry players for essential testing, supply and manufacturing partnerships. But these relationships can feel very unbalanced because large vendors seem to have far more negotiating power than any emerging company. Less favorable terms can have…

KO client Onward, which offers round-trip, door-to-door rides for older adults who need assistance, has raised $1.5 million in seed funding from Royal Street Ventures, Matchstick Ventures and JPK Capital. KO partner Kevin Gibson and attorney Elizabeth Ho represented Onward in the financing. Read more in TechCrunch.

2019 is off to a fast start in the life science, pharmaceutical and medical device industries with unprecedented market growth. Life sciences, in particular, continue on an upward trend, accounting for nearly 15 percent of venture deal flow in 2018, more than 60 percent of which were deals of $50…